1332331-08-4

1332331-08-4 structure

Name: GSK 2194069
Chemical Name: 4-[4-(1-benzofuran-5-yl)phenyl]-5-{[(3S)-1-(cyclopropylcarbonyl)-3-pyrrolidinyl]methyl}-2,4-dihydro-3H-1,2,4-triazol-3-one
CAS Number: 1332331-08-4
Molecular Formula: C₂₅H₂₄N₄O₃
Molecular Weight: 428.48300
Catalog: Research Areas Cancer
Create Date: 2018-05-22 12:25:14
Modify Date: 2025-08-25 08:03:02
GSK2194069 is a potent and specific inhibitor of the β-ketoacyl reductase (KR) activity of hFAS with an IC50 of 7.7 ± 4.1 nM in an assay detecting released CoA.IC50 value: Target: hFAS inhibitor

Name	4-[4-(1-benzofuran-5-yl)phenyl]-5-{[(3S)-1-(cyclopropylcarbonyl)-3-pyrrolidinyl]methyl}-2,4-dihydro-3H-1,2,4-triazol-3-one
Synonyms	gsk2194069

Description	GSK2194069 is a potent and specific inhibitor of the β-ketoacyl reductase (KR) activity of hFAS with an IC50 of 7.7 ± 4.1 nM in an assay detecting released CoA.IC50 value: Target: hFAS inhibitor
Related Catalog	Signaling Pathways >> Others >> Others Research Areas >> Cancer
References	[1]. Hardwicke MA, et al. A human fatty acid synthase inhibitor binds β-ketoacyl reductase in the keto-substrate site. Nat Chem Biol. 2014 Sep;10(9):774-9.